As a patient, my main focus in reviewing the rule is what it does for me. There are few changes from my original review that really impact patients here, except in:
- How ACO providers are measured on quality (the final rule uses 33 measures phased in with respect to performance, whereas the proposed rule had 65),
- The requirement that a certain percentage of ACO providers were meaningful users of HealthIT.
- That Federally Qualified Health Centers and Rural Health Centers can now form (by themselves) and better participate in ACOs (which is great if you happen to live in a rural or underserved area).
In general, the requirements for patient engagement, and patient participation in ACO governance are still present.
From the Health IT side, I was interested in how the changes impacted the Health IT industry. They removed a specific requirement on the number of ACO Professionals who are Meaningful Users, but that doesn't really worry me. Measure 11 has double weight, and is "% of providers who are meaningful users", so that will still have an ACO program impact.
My 140 character summary of the ACO rule from a Health IT perspective? "Got ACO? You'll still need EHR and HealthIT, even if the regs don't require it."
The reason for that is the amount of coordination that will be needed by members of the ACO. The point of shared savings is that the providers actually get a benefit for not duplicating work. So, if the lab was already done, and provider A has it, then provider B (and everyone else) can potentially benefit from the savings when Provider B uses the existing result. Recently my wife had knee surgery. The surgeon wanted a recent EKG. He would have been incented (under the savings model), to reuse the one my wife already had. Perhaps not as much as he might have earned from doing it over, but the world is not perfect.
There are a couple of places where Health IT and EHRs will really matter to ACOs:
- Assessing the health needs of the patient population.
- Identifying High-Risk Individuals and support of individualized care planning
- Supporting the use of evidence based medicine (e.g., through clinical decision support).
- Reporting on Quality Measures
- Managing care through an episode, including transitions between providers
- Dealing with monthly claims data and quarterly aggregates
Page 178 of the Final Rule points out that coordination of care between ACO participants and non-participants is one way to accomplish ACO goals. Amusingly enough, some commenters were looking for CMS to fund some of the IT Investments needed. CMS points these commenters to the Meaningful Use program for Health IT and EHR incentives.
For those of you who are interested in how ACOs will be measured, Table 1 from the final rule shows the quality measures (You can also find this on page 324 of the final rule text in the Federal Register Preview).
# | Domain | Measure Title | NQF Measure #/ Measure Steward | Method of Data Submission | Pay for performance R = Reporting P=Performance | ||
Year 1 | Year 2 | Year 3 | |||||
AIM: Better Care for Individuals
|
|||||||
1 | Patient/Caregiver Experience | CAHPS: Getting Timely Care, Appointments, and Information | NQF #5, AHRQ | Survey | R | P | P |
2 | Patient/Caregiver Experience | CAHPS: How Well Your Doctors Communicate | NQF #5 AHRQ | Survey | R | P | P |
3 | Patient/Caregiver Experience | CAHPS: Patients' Rating of Doctor | NQF #5 AHRQ | Survey | R | P | P |
4 | Patient/Caregiver Experience | CAHPS: Access to Specialists | NQF #5 AHRQ | Survey | R | P | P |
5 | Patient/Caregiver Experience | CAHPS: Health Promotion and Education | NQF #5 AHRQ | Survey | R | P | P |
6 | Patient/Caregiver Experience | CAHPS: Shared Decision Making | NQF #5 AHRQ | Survey | R | P | P |
7 | Patient/Caregiver Experience | CAHPS: Health Status/Functional Status | NQF #6 AHRQ | Survey | R | R | R |
8 | Care Coordination/ Patient Safety | Risk-Standardized, All Condition Readmission* | NQF #TBD CMS | Claims | R | R | P |
9 | Care Coordination/ Patient Safety | Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease (AHRQ Prevention Quality Indicator (PQI) #5) | NQF #275 AHRQ | Claims | R | P | P |
10 | Care Coordination/ Patient Safety | Ambulatory Sensitive Conditions Admissions: Congestive Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) | NQF #277 AHRQ | Claims | R | P | P |
11 | Care Coordination/ Patient Safety | Percent of PCPs who Successfully Qualify for an EHR Incentive Program Payment | CMS | EHR Incentive Program Reporting | R | P | P |
12 | Care Coordination/ Patient Safety | Medication Reconciliation: Reconciliation After Discharge from an Inpatient Facility | NQF #97 AMA-PCPI/NCQA | GPRO Web Interface | R | P | P |
13 | Care Coordination/ Patient Safety | Falls: Screening for Fall Risk | NQF #101 NCQA | GPRO Web Interface | R | P | P |
AIM: Better Health for Populations
|
|||||||
14 | Preventive Health | Influenza Immunization | NQF #41 AMA-PCPI | GPRO Web Interface | R | P | P |
15 | Preventive Health | Pneumococcal Vaccination | NQF #43 NCQA | GPRO Web Interface | R | P | P |
16 | Preventive Health | Adult Weight Screening and Follow-up | NQF #421 CMS | GPRO Web Interface | R | P | P |
17 | Preventive Health | Tobacco Use Assessment and Tobacco Cessation Intervention | NQF #28 AMA-PCPI | GPRO Web Interface | R | P | P |
18 | Preventive Health | Depression Screening | NQF #418 CMS | GPRO Web Interface | R | P | P |
19 | Preventive Health | Colorectal Cancer Screening | NQF #34 NCQA | GPRO Web Interface | R | R | P |
20 | Preventive Health | Mammography Screening | NQF #31 NCQA | GPRO Web Interface | R | R | P |
21 | Preventive Health | Proportion of Adults 18+ who had their Blood Pressure Measured within the preceding 2 years | CMS | GPRO Web Interface | R | R | P |
22 | At Risk Population - Diabetes | Diabetes Composite (All or Nothing Scoring): Hemoglobin A1c Control (<8 percent) | NQF #0729 MN Community Measurement | GPRO Web Interface | R | P | P |
23 | At Risk Population - Diabetes | Diabetes Composite (All or Nothing Scoring): Low Density Lipoprotein (<100) | NQF #0729 MN Community Measurement | GPRO Web Interface | R | P | P |
24 | At Risk Population - Diabetes | Diabetes Composite (All or Nothing Scoring): Blood Pressure <140/90 | NQF #0729 MN Community Measurement | GPRO Web Interface | R | P | P |
25 | At Risk Population - Diabetes | Diabetes Composite (All or Nothing Scoring): Tobacco Non Use | NQF #0729 MN Community Measurement | GPRO Web Interface | R | P | P |
26 | At Risk Population - Diabetes | Diabetes Composite (All or Nothing Scoring): Aspirin Use | NQF #0729 MN Community Measurement | GPRO Web Interface | R | P | P |
27 | At Risk Population - Diabetes | Diabetes Mellitus: Hemoglobin A1c Poor Control (>9 percent) | NQF #59 NCQA | GPRO Web Interface | R | P | P |
28 | At Risk Population - Hypertension | Hypertension (HTN): Blood Pressure Control | NQF #18 NCQA | GPRO Web Interface | R | P | P |
29 | At Risk Population – Ischemic Vascular Disease | Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL Control <100 mg/dl | NQF #75 NCQA | GPRO Web Interface | R | P | P |
30 | At Risk Population – Ischemic Vascular Disease | Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic | NQF #68 NCQA | GPRO Web Interface | R | P | P |
31 | At Risk Population - Heart Failure | Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | NQF #83 AMA-PCPI | GPRO Web Interface | R | R | P |
32 | At Risk Population – Coronary Artery Disease | Coronary Artery Disease (CAD) Composite: All or Nothing Scoring: Drug Therapy for Lowering LDL-Cholesterol | NQF #74 CMS (composite) / AMA-PCPI (individual component) | GPRO Web Interface | R | R | P |
33 | At Risk Population – Coronary Artery Disease | Coronary Artery Disease (CAD) Composite: All or Nothing Scoring: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Patients with CAD and Diabetes and/or Left Ventricular Systolic Dysfunction (LVSD) | NQF # 66 CMS (composite) / AMA-PCPI (individual component) | GPRO Web Interface | R | R | P |
*We note that this measure has been under development and that finalization of this measure is contingent upon the availability of measures specifications before the establishment of the Shared Savings Program on January 1, 2012.
One-Sided Model
|
Two-Sided Model
|
|||
Issue
|
Proposed
|
Final
|
Proposed
|
Final
|
Transition to Two-Sided
Model
|
Transition in third
year of first agreement period
|
First agreement period
under one-sided model. Subsequent agreement periods under two- sided model
|
Not Applicable
|
Not Applicable
|
Benchmark
|
Option 1 reset at the
start of each agreement period.
|
Finalizing proposal
|
Option 1 reset at the
start of each agreement period.
|
Finalizing proposal.
|
Adjustments for health
status and demographic changes
|
Benchmark expenditures
adjusted based on CMS-HCC model.
|
Historical benchmark
expenditures adjusted based on CMS-HCC model. Performance year: newly
assigned beneficiaries adjusted using CMS-HCC model; continuously assigned
beneficiaries (using demographic factors alone unless CMS-HCC risk scores
result in a lower risk score). Updated benchmark adjusted relative to the
risk profile of the performance year.
|
Benchmark expenditures
adjusted based on CMS- HCC model.
|
Historical benchmark
expenditures adjusted based on CMS-HCC model. Performance year : newly
assigned beneficiaries adjusted using CMS-HCC model; continuously
assigned beneficiaries (using demographic factors alone unless CMS-HCC
risk scores result in a lower risk score). Updated benchmark adjusted
relative to the risk profile of the performance year.
|
Adjustments for IME and
DSH
|
Include IME and DSH
payments
|
IME and DSH excluded
from benchmark and performance expenditures
|
Include IME and DSH
payments
|
IME and DSH excluded
from benchmark and performance expenditures
|
Payments outside Part A
and B claims excluded from benchmark and performance year expenditures;
|
Exclude GME, PQRS, eRx,
and EHR incentive payments for eligible professionals, and EHR incentive
payments for hospitals
|
Finalize proposal
|
Exclude GME, PQRS,
eRx, and EHR incentive payments for eligible professionals, and EHR
incentive payments for hospitals
|
Finalize proposal
|
Other adjustments
|
Include other adjustment
based in Part A and B claims such as geographic payment adjustments and
HVBP payments
|
Finalize proposal
|
Include other
adjustment based in Part A and B claims such as geographic payment
adjustments and HVBP payments
|
Finalize proposal
|
Maximum Sharing Rate
|
Up to 52.5 percent
based on the maximum quality score plus incentives for FQHC/RHC
participation
|
Up to 50 percent based
on the maximum quality score
|
Up to 65 percent based
on the maximum quality score plus incentives for FQHC/RHC participation
|
Up to 60 percent based
on the maximum quality score
|
Quality Sharing Rate
|
Up to 50 percent based
on quality performance
|
Finalizing proposal
|
Up to 60 percent based
on quality performance
|
Finalizing proposal
|
Participation
Incentives
|
Up to 2.5 percentage
points for inclusion of FQHCs and RHCs
|
No additional
incentives
|
Up to 5 percentage
points for inclusion of FQHCs and RHCs
|
No additional
incentives
|
Minimum Savings Rate
|
2.0 percent to 3.9
percent depending on number of assigned beneficiaries
|
Finalizing proposal
based on number of assigned beneficiaries
|
Flat 2 percent
|
Finalizing proposal:
Flat 2 percent
|
Minimum Loss Rate
|
2.0 percent
|
Shared losses removed
from Track 1
|
2.0 percent
|
Finalizing proposal
|
Performance Payment
Limit
|
7.5 percent.
|
10 percent
|
10 percent
|
15 percent
|
Performance payment
withhold
|
25 percent
|
No withhold
|
25 percent
|
No withhold
|
Shared Savings
|
Sharing above 2 percent
threshold once MSR is exceeded
|
First dollar sharing
once MSR is met or exceeded.
|
First dollar sharing
once MSR is exceeded.
|
First dollar sharing
once MSR is met or exceeded.
|
Shared Loss Rate
|
One minus final sharing
rate
|
Shared losses removed
from Track 1
|
One minus final sharing
rate
|
One minus final
sharing rate applied to first dollar losses once minimum loss rate is met
or exceeded; shared loss rate not to exceed 60 percent
|
Loss Sharing Limit
|
5 percent in first risk
bearing year (year 3).
|
Shared losses removed
from Track 1.
|
Limit on the amount of
losses to be shared phased in over 3 years starting at 5 percent in year 1;
7.5 percent in year 2; and 10 percent in year 3. Losses in excess of the
annual limit would not be shared.
|
Finalizing proposal
|
Great post Keith!
ReplyDeleteWe should also push ACOs to be required to put together patient education resources ... at the very least a website for cryin out loud. More on what doctors should be prescribing: http://www.healthcaremarketingcoe.com/health20/what_should_physicians_be_prescribing.php
Nice information about health care. I like it.
ReplyDeleteThanks ..Medical Simulation
Well written and informative. Thanks, and we will post on Twitter & LinkedIn ...
ReplyDeleteGreat work Keith! Another good reference for us. Thanks, Justin
ReplyDelete